Product approval and research status

SS-31, Elamipretide and Forzinity: which name refers to what?

SS-31 is commonly seen as a research material name, Elamipretide is the generic name of the related molecule, and Forzinity is a specific drug trade name. When checking status, you must keep the specific finished product and scope of use.

First separate the three names

Similar names help in finding information, but not all materials with the same name have the same formulation, salt form, specifications, or approval status. Catalog research materials and drug marketing records must be confirmed separately.

How are official records written?

On September 19, 2025, the FDA announced accelerated approval of Forzinity (elamipretide) injection to improve muscle strength in patients with Barth syndrome who weigh at least 30 kg. Check the current official label for the complete approved use and patient information.

This is a record for a specific finished drug, not a general approval for all SS-31 or Elamipretide catalog materials. Accelerated approval also involves follow-up confirmation requirements, so it cannot simply be written as “all efficacy has been proven.”

What information should be recorded together to be complete?

Record the jurisdiction, trade name, related generic name, finished product and route, specific use, applicable population, approval type, source, and verification date. Records from different regions cannot substitute for one another.

What else should be confirmed when viewing the NHD catalog?

Check the actual name, form, specifications, and documentation requirements of the SS-31 research material. An official drug label is not the COA of any catalog lot, and it does not automatically prove that a research material is identical to the marketed formulation.

This card helps you check status. It was reviewed on October 13, 2026; follow the official source for later updates. It does not provide individual diagnosis or treatment advice.

Original sources and further reading

• FDA: accelerated approval of Forzinity for Barth syndrome · 2025

Sources checked on 2026-10-13. Findings apply to the models and materials studied. Batch quality requires records for the actual batch.

Related research materials

Inquire about specifications, quantity, and required documentation

A clinical trial is “Completed”. Why aren’t the results available?

Completed describes the study's completion status; it does not mean you can already read a formal paper or public results. When checking progress, separate the different dates and release steps.

What is the difference between recruiting, primary completion, and overall completion?

Recruitment status describes whether participants are still being recruited. The primary completion date relates to when data collection for the primary outcome measures is finished; the study completion date also involves collection related to primary and secondary outcomes and adverse events. Read the specific fields according to the registry platform's definitions.

Why might results still not be found after Completed?

After data collection ends, organizing, analysis, submission, and quality checks may still be needed. The registry page status, results submission, results public posting, and paper publication are not the same step.

You cannot infer from the single field Completed that the results must be positive, nor can you directly interpret not finding a paper as the trial failing.

When actually checking a record, follow this order

First verify the registration number and study name, then read the population, comparison groups, and measures; then check recruitment status, primary completion date, study completion date, and record update time. If there is a results page, continue reading whether it has been made public and what was actually reported.

What if the news mentions results, but the registry page does not show them yet?

Keep the news source and date, and check whether it is a preliminary announcement, a conference abstract, or a formal paper. Record the publicly available information and the details still pending separately; do not mix different versions into a conclusion without a date.

Write the status as a record that can be updated

Record the last verification date and link to the original registry page. If the platform changes the status or adds results, simply note the change in the same record; there is no need to create a near-duplicate article for every update.

Original sources and further reading

• ClinicalTrials.gov protocol field definitions

Sources checked on 2026-10-13. Findings apply to the models and materials studied. Batch quality requires records for the actual batch.

Related research materials

Ask about specifications, quantities, and required documentation